Cytek Biosciences
NasdaqGS:CTKB
$ 4,63
$-0,08 (-1,70%)
4,63 $
$-0,08 (-1,70%)
End-of-day quote: 03/24/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,31
Earnings Per Share
$1,57
Revenue Per Share
51,84%
Gross Margin %
$0,60 B
Market Cap
$0,00 B
Long-Term Debt
Earnings Per Share
$-0,31
Revenue Per Share
$1,57
Gross Margin %
51,84%
Market Cap
$0,60 B
Long-Term Debt
$0,00 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020
EPS Earnings Per Share $-0,31 $0,18 $0,06 $0,15 $0,09 $0,13
Earnings Earnings $-39,85M $23,06M $7,85M $20,31M $12,07M $4,06M
RPS Revenue Per Share $0,00 $1,57 $1,56 $1,48 $1,21 $0,95 $0,00
Revenue Revenue $0,00M $201,49M $200,45M $193,39M $164,04M $127,95M $0,00M
OCF Operating Cash Flow $0,00M $0,00M $5,28M $5,28M $0,00M $0,00M $0,00M
FCF Free Cash Flow $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M $0,00M
OM Operating Margin 0,00% -20,04% -10,24% -14,43% -1,10% 7,16% 14,71%
GM % Gross Margin % 0,00% 51,84% 55,43% 56,69% 61,56% 61,86% 55,70%
FCFS Free Cash Flow Per Share $0,00 $-0,07 $0,17 $0,00 $-0,16 $0,00 $0,47
LT Debt Long-Term Debt N/A $0,53M $1,05M $1,65M $2,27M N/A N/A
Sha. Stocks 128,55M 128,55M 128,1M 130,82M 135,43M 134,08M 31,24M
×